Amgen's Integration of Generative AI Models for Novel Human Data Insights and Advanced Research, Supported by Exeton's Technology
January 17, 2024
Amgen's Integration of Generative AI Models for Novel Human Data Insights and Advanced Research, Supported by Exeton's Technology

Amgen, a leading biotechnology company, has embarked on a transformative journey to revolutionize drug research and development using generative AI. This case study explores how Amgen, with the support of Exeton's cutting-edge technology, is leveraging AI to analyze vast human datasets and expedite the discovery of novel health insights and therapies.
Company Overview: Amgen, a global biotech leader, has been at the forefront of medical innovation, focusing on drug discovery and development. Industry Context: The biotechnology sector is rapidly evolving, with AI technology becoming a crucial component in research and development.
Exeton's Role: Exeton provided Amgen with an NVIDIA DGX SuperPOD, featuring 31 NVIDIA DGX H100 nodes totaling 248 H100 Tensor Core GPUs, to facilitate this advanced AI-driven research.
Objectives Amgen's Goals: To harness the power of generative AI in analyzing one of the largest human datasets and to develop precision medicine models for personalized therapies.
Exeton's Contribution: To supply the necessary high-performance computing infrastructure to support Amgen's ambitious AI modeling initiatives.
Project AI Model Development: Amgen is building AI models on NVIDIA DGX SuperPOD to analyze extensive human datasets.
The Freyja System: Named in honor of the Norse goddess, Freyja will be used at Amgen’s deCODE genetics’ headquarters in Reykjavik, Iceland, for creating a human diversity atlas and developing disease-specific biomarkers and drug targets.
Precision Medicine: The project aims to enable individualized therapies for serious diseases through AI-driven models.
Impact & Outcomes
Speeding Up Research: The integration of Exeton's technology has significantly reduced the time required to train AI models, from months to days.
Enhanced Data Analysis: The ability to analyze and learn from vast datasets more efficiently has opened new avenues in health and therapeutic insights.
Advancements in Precision Medicine: The project has potential implications for personalized treatment options, shaping the future of healthcare.
Challenges & Solutions
Data Management: Handling and analyzing the sheer volume of data presented a significant challenge, met by Exeton’s robust computing capabilities.
Integrating AI with Biotech: Merging AI technology with biotechnological research required a seamless integration of hardware and software, facilitated by Exeton's expertise.
Innovations & Key Learnings
AI in Drug Discovery: Amgen’s use of AI represents a major innovation in drug discovery and development, enabling faster, more effective research.
The partnership between Amgen and Exeton demonstrates the power of collaboration between biotech companies and technology providers.
Future of Healthcare: This project is a glimpse into the future of healthcare, where AI plays a central role in understanding and treating diseases.
Amgen's initiative, supported by Exeton's technology, marks a significant milestone in the use of AI in biotechnology. The success of this project not only advances Amgen's research capabilities but also sets a precedent for the industry, showcasing the immense potential of AI in revolutionizing drug discovery and healthcare.
Recommendations for Future Endeavors
- Continue leveraging AI for broader applications in biotechnology.
- Maintain and strengthen partnerships between tech providers and biotech firms.
- Focus on developing AI models that cater to diverse and complex healthcare needs.
About Amgen
Amgen, a pioneer in biotechnology, continues to lead the industry in innovative drug research and development, now enhanced by AI technology.
About Exeton
EXETON Corp. is a dynamic and innovative technology company specializing in high-performance gaming and workstation PCs, laptops, and a wide range of accessories including keyboards, mice, joysticks, and more. Since our inception in 2019, we have expanded our offerings to include servers, mining GPUs, and streaming equipment. Headquartered in the USA, we pride ourselves on our global reach, operating in Canada, the UAE, Singapore, and delivering our top-quality products worldwide.